Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence and Consensus Based Guidelines for Imaging in Tubercular Choroiditis. Multimodal imaging in Uveitis (MUV) Taskforce: Report 17.

Ophthalmology. Retina·2026
Same author

Case Report: Longitudinal analysis of local immunoregulatory mediators in a DLBCL vitreoretinal lymphoma receiving local chemotherapy.

Frontiers in medicine·2026
Same author

Response to letter to the editor: modified flapless surgical technique for sutureless scleral fixation of FIL SSF intraocular lens.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Toxoplasma gondii retinochoroiditis associated with Epstein-Barr virus-induced retinal necrosis in an immunocompetent patient.

Journal of ophthalmic inflammation and infection·2026
Same author

Evidence and Consensus-Based Guidelines in Vogt-Koyanagi-Harada Disease. Multimodal Imaging in Uveitis (MUV) Taskforce Report 16.

Ophthalmology. Retina·2026
Same author

Choroidal abnormalities: the new hallmark ocular finding in neurofibromatosis type 1.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026
Same journal

Erratum.

Developments in ophthalmology·2021
Same journal

Pediatric Vitreoretinal Surgery and Integrated Intraoperative Optical Coherence Tomography.

Developments in ophthalmology·2021
Same journal

Integrated Intraoperative Optical Coherence Tomography for Pediatric Lamellar Corneal Transplant Surgery.

Developments in ophthalmology·2021
Same journal

The Use of Optical Coherence Tomography as an Intraoperative Adjunct of Oculoplastic Surgery.

Developments in ophthalmology·2021
Same journal

Integrated Intraoperative Optical Coherence Tomography in Strabismus Surgery.

Developments in ophthalmology·2021
Same journal

Use of Integrated Intraoperative Ocular Coherence Tomography in Pediatric Cataract Surgery: Thinking outside the Box.

Developments in ophthalmology·2021
See all related articles

Related Experiment Video

Updated: May 23, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

Corticosteroid intravitreal implants.

Marc D de Smet1

  • 1Retina and Inflammation, MIOS, Lausanne, Switzerland. mddesmet1@mac.com

Developments in Ophthalmology
|April 21, 2012
PubMed
Summary
This summary is machine-generated.

Intraocular implants using dexamethasone or fluocinolone acetonide effectively treat ocular inflammation. While both offer prolonged steroid release, the FA implant provides longer duration but may increase risks of cataract and glaucoma.

More Related Videos

Intracameral Injection in Rats with Low Risk of Adverse Effects
06:19

Intracameral Injection in Rats with Low Risk of Adverse Effects

Published on: May 31, 2024

Related Experiment Videos

Last Updated: May 23, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

Intracameral Injection in Rats with Low Risk of Adverse Effects
06:19

Intracameral Injection in Rats with Low Risk of Adverse Effects

Published on: May 31, 2024

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Biomaterials Science

Background:

  • Intraocular implants deliver glucocorticoids to the vitreous cavity for sustained ocular inflammation treatment.
  • Two main types exist: bioerodible (dexamethasone) and non-erodible (fluocinolone acetonide, FA).

Purpose of the Study:

  • To compare the efficacy and characteristics of dexamethasone and FA intraocular implants for ocular inflammation.
  • To evaluate their pharmacological similarities, neuroprotective properties, and potential side effects.

Main Methods:

  • Pharmacological comparison of dexamethasone and FA binding to glucocorticoid receptors (GR) and vitreous half-lives.
  • Review of clinical trial data on efficacy in intermediate and posterior uveitis.
  • Assessment of insertion methods, duration of action, and associated ocular side effects.

Main Results:

  • Both implants effectively inhibit intraocular inflammation in uveitis patients.
  • Dexamethasone implant (6-month duration) inserted via needle; FA implant (3-year duration) requires surgical insertion.
  • FA implant showed slightly superior efficacy to systemic therapy in the MUST trial but with increased cataract and glaucoma risk.

Conclusions:

  • Dexamethasone and FA implants are effective for ocular inflammation, offering different durations and risk profiles.
  • The choice between implants or systemic therapy depends on clinical context, disease severity, and patient factors.
  • FA implants may be favored in specific cases despite potential surgical complications.